Cogent Biosciences COGT
NASDAQ COGT
$31.88 -0.14 (-0.44%)
As of: Oct 1, 2026 · 3:32 PM EDT

Cogent Biosciences (COGT) Other Non-Current Liabilities (2017 - 2026)

Updated

Cogent Biosciences (COGT) reported Other Non-Current Liabilities of $90,000 for Q2 2026, down 96.2% from $2.36 million a year earlier but up 45.2% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Cogent Biosciences posted Other Non-Current Liabilities of $33,000.

  • Five-year quarterly Other Non-Current Liabilities spans a low of $5,000 in Q1 2025 and a high of $2.37 million in Q3 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $62,000 (Q1 2026), $33,000 (Q4 2025) and $2.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cogent Biosciences 5.49 Bn 5.49 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90,000.00
Mar 31, 2026 62,000.00
Dec 31, 2025 33,000.00
Sep 30, 2025 2.37 Mn
Jun 30, 2025 2.36 Mn
Mar 31, 2025 5,000.00
Dec 31, 2018 748,000.00
Sep 30, 2018 871,000.00
Jun 30, 2018 888,000.00
Mar 31, 2018 902,000.00
Dec 31, 2017 906,000.00
API Access

Cogent Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=COGT&period=max&api_key=YOUR_API_KEY